ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $240,882 | -18.1% | 44,199 | +0.9% | 0.13% | -19.3% |
Q2 2023 | $294,049 | -21.5% | 43,823 | +3.3% | 0.16% | -26.5% |
Q1 2023 | $374,670 | +19.1% | 42,432 | +3.0% | 0.22% | +7.9% |
Q4 2022 | $314,703 | +11.6% | 41,192 | +3.9% | 0.20% | +8.0% |
Q3 2022 | $282,000 | +141.0% | 39,658 | +173.5% | 0.19% | +113.6% |
Q2 2022 | $117,000 | -41.5% | 14,500 | +0.8% | 0.09% | -27.9% |
Q1 2022 | $200,000 | -50.1% | 14,387 | +0.6% | 0.12% | -45.8% |
Q4 2021 | $401,000 | -18.5% | 14,297 | -1.2% | 0.22% | -19.1% |
Q3 2021 | $492,000 | -18.1% | 14,470 | -1.6% | 0.28% | -18.0% |
Q2 2021 | $601,000 | +2.0% | 14,711 | +0.5% | 0.34% | -10.3% |
Q1 2021 | $589,000 | -32.1% | 14,636 | -0.3% | 0.38% | -38.6% |
Q4 2020 | $868,000 | – | 14,683 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |